CGT(세포 및 유전자 치료) 툴 및 시약 시장

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

The North American market for CGT Tools and Reagents is estimated to increase from $4.6 billion in 2024 to reach $8.2 billion by 2029, at a CAGR of 12.1% from 2024 through 2029.

The European market for CGT Tools and Reagents is estimated to increase from $2.6 billion in 2024 to reach $4.3 billion by 2029, at a CAGR of 10.5% from 2024 through 2029.

Report Scope

This report analyzes the global market for cell and gene therapy tools and reagents. The market is segmented by product type, disease or application, end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. Diseases or applications include cancer and rare diseases. End users include pharmaceutical and biotech companies, academic research institutes, and clinical laboratories. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape, and analyzes macroeconomic factors when considering new technologies, the industry's increasing competitiveness, and emerging customer needs. This report also examines analytical frameworks, such as ESG analysis, patent analysis, competitive analysis, and strategic recommendations, which will aid companies in devising their strategic plans.

Report Includes

• 44 data tables and 57 additional tables
• An update on the global market for cell and gene therapy tools and reagents
• Analyses of the global market trends, with historic market revenue for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• A look at the market potential for the cell and gene therapy tools and reagents in the life sciences industry, market drivers, and forecasts for the market segments of product, application, end user and region
• Facts and figures pertaining to major market dynamics, product innovations, clinical trials, and government regulations
• Review of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
• Coverage of the technological, economic and business considerations of the market, and the vendor landscape
• Analysis of the industry's regulatory framework and policies, and product pipeline
• Discussion of ESG challenges and ESG practices in the industry
• Market share analysis of the key companies in the industry and coverage of their proprietary technologies and strategies
• Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Sartorius CellGenix GmbH, and Miltenyi Biotec

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background: Cell Therapy
• Types of Cell Therapy
• Technology Background: Gene Therapy
• Types of Gene Therapy
• Approved CGT Products

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Investments in CGT Research
• Capacity Expansions for Clinical and Commercial Manufacturing
• Increasing Incidence of Chronic Diseases
• Collaborations and Acquisitions
• Market Restraints
• Complexity in Manufacturing and Supply Chain
• Lack of Skilled Force
• Market Opportunities
• Harnessing the Advances in CGT Technologies
• Regulatory Landscape
• Gene Therapy Regulations
• Cell Therapy Regulations
• Viral and Non-Viral Vectors
• Media
• GMP Proteins and Antibodies
• Leukapheresis
• CGT Regulations in Europe

Chapter 4 Emerging Technologies and Developments

• Closed and Automated Systems
• Single-Use Technologies

Chapter 5 Market Segmentation Analysis

• Market Trends
• Segmentation Breakdown
• Global Market for CGT Tools and Reagents, by Product
• Immunoassays
• Bioreactors
• Leukapheresis
• GMP Antibodies
• Multiplex Immunoassays
• Vectors
• Cell Separation
• Cryopreservation
• Cell Expansion
• Media
• GMP Proteins
• GMP Small Molecules
• CRS Monitoring
• Global Market for CGT Tools and Reagents, by Application
• Cancer
• Rare Diseases
• Other Diseases
• Global Market for CGT Tools and Reagents, by End User
• Pharmaceutical and Biotech Companies
• Academic and Research Institutes
• Clinical Laboratories
• Geographic Breakdown
• Global Market for CGT Tools and Reagents, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Ranking of Leading Players
• Strategies of Leading Companies
• Product Launches
• Collaborations and Partnerships
• Expansions
• Agreements
• Acquisitions
• Others

Chapter 7 Sustainability in the CGT Tool and Reagent Market: ESG Perspective

• Introduction to ESG
• ESG Performance in the Industry
• ESG Practices in the CGT Tool and Reagent Industry
• Environmental Performance
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• ABCAM LTD.
• ADVERUM BIOTECHNOLOGIES INC.
• AKRON BIOTECH
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• CYTIVA
• FUJIFILM IRVINE SCIENTIFIC
• MILTENYI BIOTEC
• PROTEINTECH GROUP INC.
• QIAGEN
• REVVITY
• SARTORIUS CELLGENIX GMBH
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.